The role of urate and xanthine oxidase inhibitors in cardiovascular disease

Cardiovascular Therapeutics

Volumn 26, Issue 1, 2008, Pages 59-64

  George, Jacob ^a   Struthers, Allan D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Allopurinol; Oxidative Stress; Urate

Indexed keywords

ALLOPURINOL; OXIPURINOL; REACTIVE OXYGEN METABOLITE; URATE; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG MECHANISM; DRUG MEGADOSE; FEVER; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HUMAN; HYPERSENSITIVITY REACTION; HYPERURICEMIA; IN VITRO STUDY; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; RASH; REVIEW; URIC ACID BLOOD LEVEL;

ALLOPURINOL; ANIMALS; CARDIOVASCULAR DISEASES; ENZYME INHIBITORS; HUMANS; URIC ACID; XANTHINE OXIDASE;

EID: 47049099695     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2007.00029.x     Document Type: Review

References (41)

1. Alper AB, Jr., Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL (2005) Childhood uric acid predicts adult blood pressure: The Bogalusa Heart Study. Hypertension 45 : 34 38.
2. Amado LC, Saliaris AP, Raju SV, Lehrke S, St John M, Xie J, Stewart G, Fitton T, Minhas KM, Brawn J, et al 2005) Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure. J Mol Cell Cardiol 39 : 531 536.
3. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Shamim W, Kemp M, et al 2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107 : 1991 1997.
4. Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555 : 589 606.
5. BNF (2007) British National Formulary; 53: March 2007.
6. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD (2000) Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35 : 746 751.
7. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, Hare JM (2001) Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104 : 2407 2411.
8. Cleland JGF, Coletta AP, Clark AL (2006) Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF. Eur J Heart Fail 8 : 764 766.
9. Ekelund UE, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, Kass DA, Marban E, Hare JM (1999) Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res 85 : 437 445.
10. Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283 : 2404 2410.
11. Farquharson CAJ, Butler R, Hill A, Belch JJF, Struthers AD (2002) Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106 : 221 226.
12. Galbusera C, Orth P, Fedida D, Spector T (2006) Superoxide radical production by allopurinol and xanthine oxidase. Biochem Pharmacol.
13. George J, Struthers A (2006) High dose allopurinol dramatically improves endothelial function beyond urate lowering and is a powerful antioxidant in chronic heart failure. Eur J Heart Failure 5 : 92.
14. Guthikonda S, Sinkey C, Barenz T, Haynes WG (2003) Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 107 : 416 421.
15. Hancock JT, Salisbury V, Ovejero-Boglione MC, Cherry R, Hoare C, Eisenthal R, Harrison R (2002) Antimicrobial properties of milk: dependence on presence of xanthine oxidase and nitrite. Antimicrob Agents Chemother 46 : 3308 3310.
16. Hayden MR, Tyagi SC (2004) Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) 1 : 10.
17. Hille R, Massey V (1981) Studies on the oxidative half-reaction of xanthine oxidase. J Biol Chem 256 : 9090 9095.
18. Hoieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, et al 2004) The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 65 : 1041 1049.
19. Ichimori K, Fukahori M, Nakazawa H, Okamoto K, Nishino T (1999) Inhibition of xanthine oxidase and xanthine dehydrogenase by nitric oxide. Nitric oxide converts reduced xanthine-oxidizing enzymes into the desulfo-type inactive form. J Biol Chem 274 : 7763 7768.
20. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ (2005) Uric acid, evolution and primitive cultures. Semin Nephrol 25 : 3 8.
21. Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K, Ishida K, Igawa O, Shigemasa C, Somers VK (2005) Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol 96 : 1576 1578.
22. Khan SA, Lee K, Minhas KM, Gonzalez DR, Raju SV, Tejani AD, Li D, Berkowitz DE, Hare JM (2004) Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci USA 101 : 15944 15948.
23. Kittleson MM, Hare JM (2005) Xanthine oxidase inhibitors: an emerging class of drugs for heart failure. Eur Heart J 26 : 1458 1460.
24. Laakso JT, Teravainen TL, Martelin E, Vaskonen T, Lapatto R (2004) Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats. J Hypertens 22 : 1333 1340.
25. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ (2001) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38 : 1101 1106.
26. Mellin V, Isabelle M, Oudot A, Vergely-Vandriesse C, Monteil C, Di Meglio B, Henry JP, Dautreaux B, Rochette L, Thuillez C, et al 2005) Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure 10.1093/eurheartj/ehi305. Eur Heart J 26 : 1544 1550.
27. Ong SL, Vickers JJ, Zhang Y, McKenzie KU, Walsh CE, Whitworth JA (2007) Role of xanthine oxidase in dexamethasone-induced hypertension in rats. Clin Exp Pharmacol Physiol 34 : 517 519.
28. Regoli F, Winston GW (1999) Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals. Toxicol Appl Pharmacol 156 : 96 105.
29. Reyes AJ, Leary WP (2003) The increase in serum uric acid induced by diuretics could be beneficial to cardiovascular prognosis in hypertension: a hypothesis. J Hypertens 21 : 1775 1777.
30. Saavedra WF, Paolocci N, St John ME, Skaf MW, Stewart GC, Xie JS, Harrison RW, Zeichner J, Mudrick D, Marban E, et al 2002) Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res 90 : 297 304.
31. Seddon M, Looi YH, Shah AM (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. 903 907.
32. Stevens CR, Millar TM, Clinch JG, Kanczler JM, Bodamyali T, Blake DR (2000) Antibacterial properties of xanthine oxidase in human milk. Lancet 356 : 829 830.
33. Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS (2005) Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 45 : 28 33.
34. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, Suematsu M, Zweifach BW, Schmid-Schonbein GW (1998) Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA 95 : 4754 4759.
35. Teng Ru-J, Ye Y-Zu, Parks DA, Beckman JS (2002) Urate produced during hypoxia protects heart proteins from peroxynitrite-mediated protein nitration. Free Radic Biol Med 33 : 1243 1249.
36. Turnheim K, Krivanek P, Oberbauer R (1999) Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects. Br J Clin Pharmacol 48 : 501 509.
37. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36 : 1072 1078.
38. Wallwork CJ, Parks DA, Schmid-Schonbein GW (2003) Xanthine oxidase activity in the dexamethasone-induced hypertensive rat. Microvasc Res 66 : 30 37.
39. Waring WS, McKnight JA, Webb DJ, Maxwell SRJ (2006) Uric Acid Restores Endothelial Function in Patients With Type 1 Diabetes and Regular Smokers. Diabetes 55 : 3127 3132.
40. Watanabe S, Tagawa T, Yamakawa K, Shimabukuro M, Ueda S (2005) Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol 25 : 2376 2380.
41. Weir CJ, Muir SW, Walters MR, Lees KR (2003) Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 34 : 1951 1956.